Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Myelodysplastic Syndromes 5Leukemia, Myeloid, Acute 4Leukemia, Myelomonocytic, Chronic 3Primary Myelofibrosis 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Leukemia, Lymphocytic, Chronic, B-Cell 2Leukemia 2Cytopenia 2Anemia, Refractory, with Excess of Blasts 2Waldenstrom Macroglobulinemia 1Thrombocythemia, Essential 1Splenomegaly 1Polycythemia Vera 1Myeloproliferative Disorders 1Multiple Myeloma 1Lymphoma, Mantle-Cell 1Leukemia, Hairy Cell 1Anemia, Refractory 1Anemia 1

Interventions

fludarabine phosphate 52Cyclophosphamide 52Peripheral Blood Stem Cell Transplantation 50Rituximab 47Mycophenolic Acid 34Whole-Body Irradiation 33Tacrolimus 26Cyclosporine 25Busulfan 23Etoposide 21Filgrastim 19Methotrexate 18Melphalan 18Antilymphocyte Serum 18Radiotherapy 15Bortezomib 15Sirolimus 12Lenalidomide 11ibrutinib 9Flow Cytometry 9Cyclosporins 9Everolimus 8Dexamethasone 8Carboplatin 8sargramostim 7Polymerase Chain Reaction 7Methylprednisolone 7Indium 7Cytarabine 7idelalisib 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Waldenstrom Macroglobulinemia × ON 01910 × Other hematologic neoplasm × Clear all
NCT00861510 2019-12-03

A Pilot Study of the Safety and Activity of Escalating Doses of ON 01910.Na in Patients With Relapsed Mantle Cell Lymphoma, Multiple Myeloma, Chronic Lymphocytic Leukemia, and Related Lymphoid Malignancies

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
16 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Leukemia, Hairy Cell, Waldenstrom Macroglobulinemia, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡